tiprankstipranks
AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily

AbbVie (4AB) Technical Analysis

17 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is -3.56, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 169.30, while AbbVie’s (4AB) share price is €169.56, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 171.95, while AbbVie’s (4AB) share price is €169.56, making it a Sell.

AbbVie (4AB) Pivot Points

Nov 26, 2024, 08:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
159.04
161.54
166.54
169.04
174.04
176.54
181.54
Fibonacci
161.54
164.41
166.17
169.04
171.91
173.67
176.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Nov 26, 2024, 08:47 PM
Period
Simple
Exponential
MA5
163.86Buy
166.06Buy
MA10
162.36Buy
166.26Buy
MA20
172.97Sell
169.30Buy
MA50
173.86Sell
171.95Sell
MA100
171.50Sell
169.59Sell
MA200
162.66Buy
162.19Buy
AbbVie’s (4AB) 10-Day exponential moving average is 166.26, while AbbVie’s (4AB) share price is €169.56, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 169.59, while AbbVie’s (4AB) share price is €169.56, making it a Sell.
AbbVie’s (4AB) stock price is €169.56 and AbbVie’s (4AB) 50-day simple moving average is 173.86, creating a Sell signal.
AbbVie’s (4AB) stock price is €169.56 and AbbVie’s (4AB) 100-day simple moving average is 171.50, creating a Sell signal.
AbbVie’s (4AB) stock price is €169.56 and AbbVie’s (4AB) 200-day simple moving average is 162.66, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Nov 26, 2024, 08:47 PM
Name
Value
Implied Action
RSI (14)
48.73
Neutral
STOCH (9,6)
70.03
Neutral
STOCHRSI (14)
33.78
Neutral
MACD (12,26)
-3.56
Buy
ADX (14)
25.37
Neutral
Williams %R
-61.87
Buy
CCI (14)
-19.95
Neutral
ATR (14)
4.43
-
Ultimate Oscillator
61.17
Neutral
ROC
-8.06
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 48.73, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 25.37, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -19.95, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -8.06, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 48.73, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is -3.56, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 163.86, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 172.97, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 173.86, which suggests 4AB is a Sell.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 162.66, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -61.87, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -19.95, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis